Imad Al-Dakkak - Alexion, AstraZeneca Rare Disease

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 21 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

#243 Characteristics and Safety in Patients with Atypical Haemolytic Uraemic Syndrome Switching to Ravulizumab from Eculizumab: a Global Registry Analysis

Franz Schaefer,Imad Al-Dakkak,Nuria Saval,David Cohen,Laurence A. Greenbaum,Gema Ariceta

NEPHROLOGY DIALYSIS TRANSPLANTATION (2024): I18-I20

引用0浏览0引用

Incidence and Outcome of Meningococcal Infection with Eculizumab or Ravulizumab in Patients with Gmg or NMOSD: an Analysis of US Clinical Practice

Shirali Pandya, Lokesh Jha,Imad Al-Dakkak, Feifei Yang, Vidya Chitikireddi, Hua Zhang,Arshad Mujeebuddin

Neurologyno. 7_Supplement_1 (2024)

引用0浏览0引用

Safety and Effectiveness of Switching to Ravulizumab from Eculizumab in Kidney Transplant Recipients with Atypical Hemolytic Uremic Syndrome: A Global Registry Analysis

Anja H. Gaeckler,Imad Al-Dakkak,Nuria Saval, Hans Herman Dieperink, Margriet Eygenraam, Larry A. Greenbaum,Nicole Isbel,Johan Vande walle

Journal of the American Society of Nephrologyno. 10S (2024)

引用0浏览0引用

Characterization of Patients with Ahus and Associated Triggers or Clinical Conditions: A Global Ahus Registry Analysis

Christoph Licht,Imad Al-Dakkak,Katerina Anokhina,Nicole Isbel,Veronique Fremeaux-Bacchi,Rodney D. Gilbert,Larry A. Greenbaum,Gema Ariceta,Gianluigi Ardissino,Franz Schaefer,Eric Rondeau

Nephrology (2024)

引用0浏览0WOS引用

Real-World Analysis of the Underdiagnosis, Clinical Outcomes and Associated Burden of Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy (HSCT-TMA) in the United States of America

Yan Wang,Andrew Rava, Marlene Smuzynski,Bonny Shah,Anusorn Thanataveerat,Imad Al Dakkak,Moh-Lim Ong,Christopher C. Dvorak,Vincent Ho

Transplantation and Cellular Therapyno. 2 (2024): S130-S131

引用0浏览0引用

Global Ahus Registry Analysis of Patients Switching to Ravulizumab from Eculizumab

Franz Schaefer,Imad Al-Dakkak,Katerina Anokhina,David Cohen,Larry A. Greenbaum,Gema Ariceta

Journal of the American Society of Nephrologyno. 11S (2023): 987-987

引用0浏览0WOS引用

Atypical Hemolytic Uremic Syndrome Treated with Ravulizumab or Eculizumab: A Claims-Based Evaluation of Health Care Resource Utilization and Clinical Outcomes in the United States

Yan Wang,Imad Al-Dakkak,Katherine Garlo,Moh-Lim Ong,Ioannis Tomazos,Arash Mahajerin

KIDNEY MEDICINEno. 8 (2023)

引用0浏览0WOS引用

#3074 changes in the clinical characteristics and management of patients with ahus over 10 years: trends from the global ahus registry

Andrew Siedlecki,Imad Al-Dakkak,Katerina Anokhina,Gema Ariceta,Gianluigi Ardissino,Laurence A. Greenbaum,Christoph Licht,Johan Van de Walle

Nephrology Dialysis Transplantationno. Supplement_1 (2023)

引用0浏览0引用

FC 115: Long-Term Outcomes in Eculizumab-Treated Kidney Transplant Patients Enrolled in the Global Atypical Haemolytic Uraemic Syndrome Registry

Maria Gema Ariceta Iraola,Imad Al-Dakkak,Katerina Anokhina,Gianluigi Ardissino,Laurence A. Greenbaum,Gurinder Kumar,Christoph Licht,Andrew Siedlecki,Johan Van de Walle

Nephrology, dialysis, transplantation/Nephrology dialysis transplantation（2022）

引用0浏览0引用

Characterization of Patients with Ahus and Triggering/Associated Events, with and Without Complement Pathogenic Variants or Anti-Cfh Antibodies: A Global Ahus Registry Analysis

Andrew Siedlecki,Imad Al-Dakkak,Katerina Anokhina,Nicole Isbel,Veronique Fremeaux-Bacchi,Rodney Gilbert,Laurence Greenbaum,Gema Ariceta,Gianluigi Ardissino,Franz Schaefer,Eric Rondeau,Christoph Licht

Blood（2022）

引用3浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn